くすりのしおり

Internal
Revised: 4/2018

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
Vepesid Capsules 50 mg
 Active ingredient:
Etoposide
 Dosage form:
light orange capsule, size 2 capsule, major axis: 17.9 mm, minor axis: 6.3 mm
 Print on wrapping:
(Face) VEPESID 50 mg BMS305 (Back) ペプシド 50 mg

Effects of this medicine

This medicine shows cancer cell-killing effect on cancer cell by inhibiting enzymes related to DNA (deoxyribonucleic acid) division during cell division.
It is usually used to treat small-cell lung cancer, malignant lymphoma, cervical cancer and ovarian cancer progressed after chemotherapy.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have liver disorder, renal disorder, bleeding tendency, infection or chicken pox.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • For small-cell lung cancer: In general, for adults, take 175 to 200 mg of the active ingredient a day for 5 consecutive days, and discontinue the medication for 3 weeks.
    For malignant lymphoma: Either Method A or Method B is selected depending on the condition. (Method A) In general, for adults, take 175 to 200 mg of the active ingredient a day for 5 consecutive days, and discontinue the medication for 3 weeks. (Method B) In general, for adults, take 50 mg of the active ingredient a day for 21 consecutive days, and discontinue the medication for 1 to 2 weeks.
    For cervical cancer: In general, for adults, take 50 mg of the active ingredient a day for 21 consecutive days, and discontinue the medication for 1 to 2 weeks.
    For ovarian cancer progressed after the other chemotherapy: In general, for adults, take 50 mg/m2 a day for 21 consecutive days, and discontinue the medication for 1 week.
    In any case, this is regarded as one course, which is repeated. The dosage may be adjusted according to your age or symptoms in small-cell lung cancer and malignant lymphoma. The dosage may be decreased according to your age or symptoms in cervical cancer and ovarian cancer. This medicine contains 50 mg of the active ingredient in a capsule. Strictly follow the instructions.
  • If you miss a dose, take the prescribed dosage when you notice. You can take more than one dose within the day you missed a dose, but you should never take two-days doses at one time. Take the next dose at the prescribed schedule.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

  • Be sure to visit your doctor periodically to check the effects and adverse drug reactions of the medicine.
  • If you or your partner have a possibility of pregnancy, avoid pregnancy while you are taking this medicine and for a certain period after you discontinue this medicine.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include anemia, loss of hair, loss of appetite, nausea/vomiting, malaise, stomatitis, diarrhea and constipation. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • anemia, fever, bleeding tendency [bone marrow suppression]
  • fever, cough, breathing difficulty [interstitial pneumonia]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store away from direct sunlight, heat and moisture.
  • Discard the remainder. Do not store them. Ask your pharmacist or medical institution how to discard them.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.